Eli Lilly has linked lepodisiran to sustained reductions in a cardiovascular disease risk factor for nearly 1.5 years, bolstering the company’s argument that the siRNA candidate has an edge over ...

In the coming two weeks, the FDA is expected to announce three big decisions, including one for a dry eye disease therapy.

American Century Companies Inc. gave Amgen a financial haircut, slashing its stake by 46.3% and cashing in $36.76 million.

CHICAGO (Reuters) -The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a ...